AGARWALEYE Q1 FY27 results at a glance
DR AGARWALS HEALTH CARE L Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹614 cr |
|---|
| Revenue YoY | +26.0% |
|---|
| Operating profit | ₹92.1 cr |
|---|
| Operating margin | 15.0% |
|---|
| Net profit | ₹45.23 cr |
|---|
| Net profit YoY | +50.5% |
|---|
| Net profit QoQ | +13.9% |
|---|
| Net margin | 7.4% |
|---|
| Basic EPS | ₹1.43 |
|---|
| TTM revenue | ₹2,195 cr |
|---|
| TTM net profit | ₹149 cr |
|---|
| TTM net margin | 6.8% |
|---|
AGARWALEYE Q1 FY27 results: what the numbers say
DR AGARWALS HEALTH CARE L (AGARWALEYE) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹614 cr and a net profit of ₹45.23 cr, translating into earnings per share of ₹1.43.
Compared with the same quarter a year earlier, revenue grew strongly by +26.0% and net profit grew sharply by +50.5%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹92.1 cr, an operating margin of 15.0% versus 13.3% a year ago — a gain of 1.7 percentage points.
AGARWALEYE quarter-wise results table
Net profit
₹45.23 cr
+50.5% YoY
Operating profit
₹92.1 cr
+41.9% YoY
DR AGARWALS HEALTH CARE L (AGARWALEYE) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹614 cr | ₹92.1 cr | ₹45.23 cr | 15.0% | 7.4% | ₹1.43 | +50.5% | +13.9% |
| Q4 FY262026-03-31 | ₹564 cr | ₹84.79 cr | ₹39.71 cr | 15.0% | 7.0% | ₹1.25 | +21.9% | +17.7% |
| Q3 FY262025-12-31 | ₹530 cr | ₹75.35 cr | ₹33.74 cr | 14.2% | 6.4% | ₹1.07 | — | +12.3% |
| Q1 FY262025-06-30 | ₹487 cr | ₹64.91 cr | ₹30.05 cr | 13.3% | 6.2% | ₹0.95 | — | -7.7% |
| Q4 FY252025-03-31 | ₹460 cr | ₹70.6 cr | ₹32.57 cr | 15.3% | 7.1% | ₹1.04 | — | — |
| TTM (last 4 quarters) | ₹2,195 cr | ₹317 cr | ₹149 cr | 14.4% | 6.8% | ₹4.70 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
AGARWALEYE quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
DR AGARWALS HEALTH CARE L quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹614 cr | ₹564 cr | ₹530 cr | ₹487 cr | ₹460 cr |
|---|
| Total expenses | ₹522 cr | ₹479 cr | ₹455 cr | ₹423 cr | ₹390 cr |
|---|
| Gross profit | ₹396 cr | ₹367 cr | ₹333 cr | ₹307 cr | — |
|---|
| Operating profit (EBIT) | ₹92.1 cr | ₹84.79 cr | ₹75.35 cr | ₹64.91 cr | ₹70.6 cr |
|---|
| Operating margin | 15.0% | 15.0% | 14.2% | 13.3% | 15.3% |
|---|
| Interest cost | ₹23.37 cr | ₹22.08 cr | ₹21.13 cr | ₹24.7 cr | ₹25.01 cr |
|---|
| Profit before tax | ₹75.14 cr | ₹76.62 cr | ₹64.76 cr | ₹53.6 cr | ₹58.52 cr |
|---|
| Tax expense | ₹20.12 cr | ₹26.66 cr | ₹21.13 cr | ₹15.54 cr | ₹15.97 cr |
|---|
| Effective tax rate | 26.8% | 34.8% | 32.6% | 29.0% | 27.3% |
|---|
| Net profit (PAT) | ₹45.23 cr | ₹39.71 cr | ₹33.74 cr | ₹30.05 cr | ₹32.57 cr |
|---|
| Net profit margin | 7.4% | 7.0% | 6.4% | 6.2% | 7.1% |
|---|
| Basic EPS | ₹1.43 | ₹1.25 | ₹1.07 | ₹0.95 | ₹1.04 |
|---|
| Diluted EPS | ₹1.42 | ₹1.24 | ₹1.06 | ₹0.95 | ₹1.03 |
|---|
AGARWALEYE results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|
| Revenue YoY | +26.0% | +22.6% | — | — | — |
|---|
| Revenue QoQ | +8.8% | +6.5% | +8.7% | +5.9% | — |
|---|
| Operating profit YoY | +41.9% | +20.1% | — | — | — |
|---|
| Operating profit QoQ | +8.6% | +12.5% | +16.1% | -8.1% | — |
|---|
| Net profit YoY | +50.5% | +21.9% | — | — | — |
|---|
| Net profit QoQ | +13.9% | +17.7% | +12.3% | -7.7% | — |
|---|
| EPS YoY | +50.5% | +20.2% | — | — | — |
|---|
| EPS QoQ | +14.4% | +16.8% | +12.6% | -8.7% | — |
|---|
AGARWALEYE annual results history
Full-year performance for DR AGARWALS HEALTH CARE L, useful for reading each quarter in context.
DR AGARWALS HEALTH CARE L annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹2,077 cr | ₹1,705 cr | ₹1,328 cr | ₹1,016 cr |
|---|
| Total expenses | ₹1,770 cr | ₹1,456 cr | ₹1,126 cr | ₹863 cr |
|---|
| Gross profit | ₹951 cr | ₹769 cr | ₹599 cr | ₹458 cr |
|---|
| Operating profit (EBIT) | ₹307 cr | ₹249 cr | ₹202 cr | ₹154 cr |
|---|
| Operating margin | 14.8% | 14.6% | 15.2% | 15.1% |
|---|
| Interest cost | ₹90.34 cr | ₹108 cr | ₹95.62 cr | ₹71.97 cr |
|---|
| Profit before tax | ₹249 cr | ₹160 cr | ₹141 cr | ₹83.59 cr |
|---|
| Tax expense | ₹80.5 cr | ₹49.51 cr | ₹45.52 cr | -₹19.64 cr |
|---|
| Effective tax rate | 32.4% | 31.0% | 32.4% | -23.5% |
|---|
| Net profit (PAT) | ₹133 cr | ₹83.46 cr | ₹83.06 cr | ₹94.1 cr |
|---|
| Net profit margin | 6.4% | 4.9% | 6.3% | 9.3% |
|---|
| Basic EPS | ₹4.21 | ₹2.80 | ₹2.63 | ₹2.98 |
|---|
| Diluted EPS | ₹4.18 | ₹2.78 | ₹2.63 | ₹2.98 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹614 cr against ₹487 cr in Q1 FY26, and ₹564 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +8.8%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹522 cr, or 85.0% of revenue, with operating profit grew +41.9% year on year.
Margins, tax and profitability
Net profit of ₹45.23 cr works out to a net margin of 7.4% compared with 6.2% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, DR AGARWALS HEALTH CARE L reported profit before tax of ₹75.14 cr, a tax charge of ₹20.12 cr (effective rate 26.8%), interest cost of ₹23.37 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹39.71 cr in Q4 FY26 to ₹45.23 cr in Q1 FY27, a change of +13.9%.
Trailing twelve months and annual context
Across the trailing four quarters DR AGARWALS HEALTH CARE L has generated revenue of ₹2,195 cr and net profit of ₹149 cr, a trailing net margin of 6.8%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹2,077 cr with net profit of ₹133 cr and EPS of ₹4.21, versus the prior year where revenue grew +21.9% and profit grew +59.6%.
What to watch in the next AGARWALEYE quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
DR AGARWALS HEALTH CARE L has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
AGARWALEYE results coverage
No results report published for AGARWALEYE yet — our desk covers each quarter within minutes of the filing.
AGARWALEYE quarterly results FAQs
What were DR AGARWALS HEALTH CARE L (AGARWALEYE) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), DR AGARWALS HEALTH CARE L reported revenue of ₹614 cr and net profit of ₹45.23 cr, a change of +50.5% year on year on +26.0% revenue growth. EPS stood at ₹1.43.
What is AGARWALEYE profit margin in Q1 FY27?
DR AGARWALS HEALTH CARE L posted a net profit margin of 7.4% and an operating margin of 15.0% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹2,195 cr and net profit ₹149 cr.
Did AGARWALEYE results beat the previous quarter?
DR AGARWALS HEALTH CARE L net profit changed +13.9% quarter on quarter, from ₹39.71 cr in Q4 FY26 to ₹45.23 cr in Q1 FY27.
When are DR AGARWALS HEALTH CARE L (AGARWALEYE) quarterly results?
DR AGARWALS HEALTH CARE L has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see AGARWALEYE latest quarterly results?
Results coverage for AGARWALEYE will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the AGARWALEYE stock page.
What is DR AGARWALS HEALTH CARE L annual revenue and profit?
For FY26, DR AGARWALS HEALTH CARE L reported full-year revenue of ₹2,077 cr and net profit of ₹133 cr, with EPS of ₹4.21.
How many quarterly results has AGARWALEYE declared recently?
Past results dates for AGARWALEYE will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
